COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #17 of 231
4/21 Early treatment study
Izoulet M., SSRN, doi:10.2139/ssrn.3575899 (Preprint)
Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths
Source   PDF   Share   Tweet
Compares the dynamics of daily deaths in the 10 days following the 3rd death in countries using and not using [H]CQ, showing dramatically lower death in [H]CQ countries. This paper does not attempt to account for population age and other differences between the countries and recommends further study.

Izoulet et al., 4/21/2020, retrospective, multiple countries, multiple regions, preprint, 1 author, dosage not specified.
risk of death, 85.0% lower, RR 0.15, p < 0.001.
Details of all 231 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit